CRS IS HIRING!
Join the Clinical Research Strategies team of talented and accomplished professionals serving the Life Sciences industry.
We CARE about your BIG dreams and limited means.
We are with our clients for the long haul — the ups and downs — supported by resilience and pragmatism.
Clinical Research Strategies is a Pittsburgh, PA-based contract research organization and executive management consultancy for start-up and mid-size life sciences companies. We help instill fiscal discipline and reduce risks in clinical development, corporate affairs, and quality assurance programs.
Project-specific, fit-for-purpose, ad hoc consulting, and staffing clinical trials is what we do best, whatever stage your program is in.
CRS advisors have been everywhere – clinical research organizations, life science start-ups, and large pharma and medical device companies.
We can help you manage and overcome complicated trial operations and the burdensome regulatory pathways to a successful product launch.
To improve your business’ performance and provide a successful clinical research development plan and strategy.
Our guiding principles are:
We’d Love to Learn about Your Program.
CRS TEAM UPDATES
Congratulations to CRS Clinical Research Associate, Samantha Krebs, for completing Barnett’s CRA & CRC Beginner Program!
The 10-week program provides a comprehensive introduction to clinical research and the job functions of the Clinical Research Associate (CRA) and Clinical Research Coordinator (CRC) for drug, biologic, and device trials.
Samantha is using this training to further her studies in the field of life sciences and to grow in her role as a CRA.
CRS Welcomes Tracey Myers!
Clinical Research Strategies welcomes Tracey Myers as our new intern for the next 16 weeks beginning October 23. Tracey is a PhD Candidate in the Center for Neuroscience at the University of Pittsburgh. Her graduate work focuses on the development of therapeutics for triosephosphate isomerase deficiency, an ultra-rare neuromuscular disease. Tracey is interested in clinical research and passionate about bringing novel therapies from bench-to-bedside.
CRS is collaborating with the University of Pittsburgh to provide interns with experience in clinical and regulatory affairs, medical writing, consulting, and business development. Tracey will work with the CRS team to gain an understanding of clinical trials and the different steps involved in bringing new technologies to a place of impact.
Please join the entire CRS team as we welcome Tracey!
CRS Congratulates Olivia Moore, Our Recent Intern!
CRS has an Undergraduate Internship Affiliation Agreement with Penn State to provide students with real world clinical research experience that supplements what they learn in the classroom. Their Special Topics course focuses on the practice of clinical research as a cornerstone to academic medicine and research, using novel approaches to treat disease while forging new best practices in clinical care. Together with the opportunity for internships, this course is a keystone part of Penn State’s Clinical Research Program.
CRS congratulates our recent intern, Olivia Moore, a senior at Penn State Greater Allegheny, majoring in biobehavioral health. Her career goal is to be involved in clinical research. While at CRS, she was an integral part of our team, learning what clinical trial management involves, and a little about the associated regulatory requirements.
Olivia found her experience at CRS to be rewarding, stating, “This internship was incredibly educating and eye-opening to understanding the world of clinical research and all that it entails. Being a part of this internship has opened my eyes to different occupational opportunities that I may enjoy taking part of in the future.”
Please join the entire CRS team as we congratulate Olivia!
CRS Ranks #34 in the 2023 Pittsburgh Business Times List of Life Sciences / Medical Device Companies
The region’s biotech ecosystem remains strong in Pittsburgh — fueled by the presence of UPMC, Highmark/Allegheny Health Network and fed by the University of Pittsburgh, Carnegie Mellon University, Duquesne University and other regional institutions — as is evidenced by the companies on the List of Life Sciences and Medical Device Firms in the Pittsburgh region.
The CRS Senior Management Team Helps Enable Growth and Awareness at the Local University Levels.
Parul Nisha, PhD, Senior Director, Clinical and Regulatory Affairs at CRS, making a difference and giving back as she presents her expertise to the next generation of Biomedical Engineering students at Duquesne University.
CRS is proud of our teammates, Julie Cramer, PhD, MS (judge) and Parul Nisha, PhD (judge), for their support of the Pittsburgh Regional Science & Engineering Fair at the Carnegie Science Center. Thank you for your civic involvement!
Julie Cramer, PhD, Associate Director of Clinical and Regulatory Affairs at CRS, presents a seminar to the University of Pittsburgh biomedical graduate students who are in the Cellular Approach to Tissue Engineering and Regeneration (CATER) program, funded by a T32 grant. Julie, a former member of the CATER program and Pitt grad student herself, says, “It feels great to give back!”
It was a great honor to be invited alongside representatives from Philips, Covestro, and ZOLL Medical Corporation to Leda Klouda, PhD’s Biomedical Engineering Department and the Biomedical Engineering Society Career Event at Duquesne University held on March 30, 2022. Our Clinical Research Strategies, LLC teammates, Brian Sullivan and Julie Cramer, were thrilled to provide highlights of their own career trajectories (education, first and subsequent jobs) and speak about our company’s products, market, and customers. Thank you, Leda Klouda, PhD and students!
MEET THE CRS TEAM
DAVID LINK, MBA
CEO and Chief Quality & Regulatory Officer
For more than three decades, David has been an innovative and transformative leader with progressive accomplishments in Quality Engineering, Quality Assurance, and Quality Management for market-leading technology and medical device manufacturers. He brings to CRS a proven track record of assuring customer quality satisfaction and improving profitability by identifying critical priorities, marshaling commitment, and managing cross-functional teams to successfully execute. David is results-driven by solving complex problems, driving change, and fostering and enabling quality culture for learning and improvement.
President, Chief Operating Officer & Founder
Alethea brings 30-plus years of expertise in analyzing the intersection of healthcare innovation and policy; providing flexible clinical trial resourcing; developing sustainable corporate affairs programs and policies; training and managing resilient, high-performing clinical operations teams; mitigating risks of clinical trials; and facilitating transparent, accountable sponsor-CRO partnerships. She is the recipient of the 2017 Governor Tom Wolf Recognition in PA Life Sciences, 2017 Women in Bio P.O.W.E.R. Award, and 2017 Pittsburgh City Council Recognition in Life Sciences.
Manager of Business Operations
Candice earned her bachelors of science (BS) in business management from North Carolina State University. She has held various roles with increasing responsibility, including in financial consulting, billing, bank reconciliation, and financial reporting for small, mid-size, and large companies. Candice and her family spend significant time giving back to their community, including with food banks and other mentoring for those less fortunate. Ms. Brett lives in North Carolina with access to numerous CRS clients, including emerging life sciences companies and other existing partnerships.
JULIE CRAMER, PhD, MS
Director of Clinical and Regulatory Affairs
Julie earned her PhD from the University of Pittsburgh in Pathology, with a focus on intestinal stem cells and their link to intestinal cancer. When the opportunity came to join a local life sciences startup that had licensed a technology from the University of Pittsburgh, she embraced the challenge and quickly came to understand how it takes careful management of a cross-disciplinary team to navigate the often turbulent entrepreneurial waters.
Dr. Cramer then returned to her alma mater to work in commercial translation at the University of Pittsburgh’s Innovation Institute. Acting as liaison to the University’s close clinical partner, UPMC, Dr. Cramer managed diverse programs, including digital health and immunotherapy, to enable nascent technologies to mature into valuable intellectual property ready for licensing.
Manager of Quality and Regulatory Compliance
Vonya earned a bachelor’s degree with honors from Cornell University in biological and environmental engineering, and a master’s degree from Case Western University in biomedical engineering. She began her career working to determine genes responsible for mucus production in cystic fibrosis patients, carrying out toxicity studies to determine lethal dose of novel antibiotics on mice, and developing acute lung infection mice models.
After several years in a senior research assistant role at Magee Women’s Research institute (MWRI) studying gene expression of nicotine in lung fibroblasts and differentiating embryonic stem cells, Ms. Eisinger joined Perryman Company and held several roles in quality assurance, most significantly within the medical device sector where she analyzed validation requirements, requests for information, documentation, and complaint handling under ISO standards. Ms. Eisinger also participated in ISO 9001, AS9100, ISO 13485, and customer audits.
FRANK FALCIONE, EMBA
Senior Executive Quality and Risk Management Consultant
Frank has 30 years’ experience as a senior executive working in domestic and international regulatory compliance, inspection-readiness, regulatory negotiations, quality management systems, and new product development within start-up medical device companies, military applications, and diagnostic instrumentation.
Mr. Falcione has contributed more recently to the implementation of MDD Class IIb and III devices for CE approval, transition to EU MDR conformance, and FDA Class III Modular PMA submissions. Additionally, he led quality programs for inspection-readiness, on-site and virtual audits and inspections, and face-to-face regulatory meetings. He remains actively involved in teaching regulatory/quality and product risk management at local colleges and universities and contributing to the development of young entrepreneurs.
Senior Clinical and Quality Specialist/Auditor
Ms. Foust earned a bachelor’s degree in biochemistry and molecular biology from The Pennsylvania State University. Ms. Foust began her career working at a CLIA-certified molecular medicine laboratory handling complex molecular assays and systems. She prepared sequencing libraries while also testing and evaluating new reagents and controls. Her career growth enabled her to move into GLP genetic toxicology assays, quality assurance, and report generation.
Kaysie moved from North Carolina to Pittburgh to work at Noveome Biotherapeutics (formerly Stemnion Inc.) where as a quality control analyst II, she spearheaded cGMP and cGLP work that supported product development. Her next move was with Interpace Diagnostics as a senior laboratory technologist, followed by a position as specialty laboratory technologist at the University of Pittsburgh Medical Center (UPMC) Genome Center. Prior to joining CRS, Ms. Foust worked at ALung Technologies in Quality Assurance.
In her spare time Kaysie volunteers for Lake Erie and Presque Isle clean-up initiatives and is passionate about supporting animal shelters.
HALEY FULLER, PhD
Clinical and Regulatory Affairs Scientist
Dr. Fuller earned her doctorate of philosophy in bioengineering from the University of Pittsburgh’s Swanson School of Engineering while conducting extensive research in on-a-chip systems, multi-scale robotics, and precision medicine as a part of the Synthetic Biology and Biomimetics Laboratory of Warren Ruder, PhD.
Haley was a Cardiovascular Bioengineering Training Program T-32 Fellow and collaborated with interdisciplinary research teams at the University of Pittsburgh Vascular Medicine Institute and the UPMC Heart and Vascular Institute. In this role, Haley assisted with the engineering of organ-on-a-chip devices to understand and treat cardiovascular pathogenesis. She used these systems to evaluate drug-laden microrobot localization and drug release efficacy as a demonstration of microrobots as targeted drug delivery systems.
A pivotal point in Dr. Fuller’s research career was a stint as a bioprocess engineer at the National Institute of Allergy and Infectious Disease (NIAID), where she was instrumental in conceptualizing DoE and high-throughput experimental approaches for vaccine candidate purification process optimization. Her efforts resulted in the development of clinical manufacturing processes, a high-throughput resin screen, and data generation for peer-reviewed scientific manuscripts.
SHEILA GRAB, PhD
Clinical and Regulatory Affairs Scientist Consultant
Sheila earned her PhD in Pharmaceutical Sciences from the University of Pittsburgh’s School of Pharmacy, and Bachelor of Science degree from Pennsylvania State University. She has a breadth of experience in pre-clinical, clinical, and translational research focused on device, drug, biologic, and combination products for a range of indications. Additionally, she brings our clients more than five years of extensive experience in clinical trial management, regulatory submissions, pharmaceutical formulation, manufacture, characterization, and general laboratory procedures. Dr. Grab is highly adept at management consulting by juggling a variety of projects using her skills in scientific writing for SOPs, protocol development, grants, Investigator Brochures, Instructions for Use, and various other clinical-related documents, as well as regulatory research for US and international submissions. She serves as vice-chair of Young Women in Bio (YWIB) Pittsburgh Chapter and as a Women in Bio (WIB) Pittsburgh Chapter Member.
ALYSSA HARRIS, MS
Senior Clinical and Regulatory Affairs Project Lead
Alyssa serves as a project lead II at CRS and is responsible for managing multiple trials involving medical devices and drug development research in critical care, GI surgery, abdominoplasty, oncology, infectious diseases, respiratory disorders, and digital therapeutics. Ms. Harris also has experience managing federally funded research programs in vulnerable populations, specifically in the neonatal intensive care unit.
Alyssa earned her master’s degree from the University of Pittsburgh in Health, Physical Activity and Chronic Disease, focusing on the research track. Her undergraduate degree is in Exercise Physiology, where Ms. Harris gained extensive experience working in chronic disease research, specifically with metabolic disorders, and leading weight loss and physical activity interventions. Ms. Harris brings a unique range of expertise to CRS, and thrives in an environment that uses new methods and tools in research.
Clinical Research Associate
Samantha earned a bachelor’s degree in biobehavioral health from Pennsylvania State University (PSU). She took focused coursework in Clinical Research Practice, Health Promotion II, Anatomy and Physiology II, Chemistry Principles II, Epidemiology, Genetics, Statistics, Research Applications, Diversity and Health, Bioethics, Kinesiology, Nutrition, and Psychology.
Samantha completed numerous certifications in the research and medical field, including: First Aid & CPR and Mental Health First Aid; CITI Programs Biomedical Human Subject Research (IRB) Course, FDA-Regulated Research, OSHA Bloodborne Pathogens, Shipping of Regulated Biological Material; and, Professional Development Certification for Center-Based Care (Building Blocks for Quality). Her leadership skills were honed by chairing the 2021-22 THON and coaching club field hockey. In her spare time, Samantha enjoys hiking, fishing, and anything outdoors.
SIDNEY LANE, PhD
Clinical and Regulatory Affairs Project Lead
Dr. Lane earned a doctorate in Microbiology and Immunology from the University of Pittsburgh, School of Medicine, conducting extensive research on immune dysfunction and host-microbe interactions during polymicrobial respiratory infections in the laboratory of Dr. Jennifer Bomberger, PhD.
Sidney’s research led to multiple peer-reviewed publications and fellowships, including an appointment as a TL1 Clinical and Translational Sciences Fellow. In this role, Sidney expanded her clinical research knowledge through coursework and a personalized training program, allowing her to grow her passion for life sciences research translation. Following her time as a TL1 Fellow, Sidney joined the CRS team as the inaugural intern in the newly established partnership between CRS and the University of Pittsburgh. Outside of the workplace, Sidney loves to play with her dog and enjoys yoga, bouldering, and staying up-to-date on her favorite home renovation shows.
JENNIFER LE, PHARM.D.
Clinical and Regulatory Affairs Project Lead
Jennifer earned her doctorate of pharmacy from the University of Rhode Island, School of Pharmacy. She recently completed a 5-month long internship with CRS and landed her role by proving exceptional performance, know-how, and character.
Dr. Le currently serves as a project lead at CRS where she is involved in clinical trials for medical devices and drugs, regulatory submissions, and medical writing. She has experience managing clinical data, writing documents such as informed consent forms, preparing 510k submissions, and facilitating correspondences with the FDA. Dr. Le enjoys utilizing her pharmaceutical knowledge and critical thinking skills at CRS to provide exceptional clinical research services to our clients and continue fostering innovation.
LAURA LUND, PhD
Senior Executive Management Consultant
Dr. Laura Lund is an accomplished medical device development and commercialization expert, having spent significant time in the industry as a mechanical bioengineer, including extensive experience in global regulatory and clinical strategy, both pre- and post-market. She has expertise in journal publications, regulatory submissions, sales and marketing materials, IP development, training materials, investor decks, collaborations with medical advisory boards, and presenting at conferences. She is well-versed with the design, implementation, and regulatory requirements for pre-clinical in vitro and in vivo testing.
Dr. Lund’s therapeutic areas include drugs, biologics, and medical devices in the following areas: critical/intensive cardiopulmonary care, mechanical ventilation, ECMO, ECCO2R, artificial hearts (LVAD, RVAD, TAH), intra-aortic balloon pumps, central venous catheters/cannulation, continuous dialysis, high-pressure contrast injection, imaging, digital therapeutics, COVID-19 in vitro diagnostics; COPD, ARDS, acute respiratory failure, asthma, cystic fibrosis, heart/lung transplantation; Digital Therapeutics, Software as a Medical Device (SaMD), In vitro Diagnostics (IVDs); 3D bioprinted regenerative medicine; central nervous system (CNS); oncology; and many more.
Our Supplementary Team is Ready for Your Assignment!
Project Management Directors and Project Managers
- Experts from CRO, Sponsor & Site side
- ≥ 10-20 years’ experience in research and consulting services
- Cardiovascular, oncology, regenerative medicine, CNS, women’s/men’s health, implantable devices, vaccines, infectious diseases, GI, metabolic, immuno-oncology, respiratory, rheumatology, nephrology, rare diseases… and many others
Senior Clinical Research Associates / Auditors
Experts from CRO, Sponsor & Site side
≥ 20-30 years’ experience in research and consulting services
Cardiovascular, oncology, regenerative medicine, CNS, women’s/men’s health, implantable devices, vaccines, infectious diseases, GI, metabolic, immuno-oncology, respiratory, rheumatology, nephrology, rare diseases… and many others
Senior Scientist Executives
Experts from Sponsor & Government Firms
≥ 15-30 years experience in life sciences
Drug, biologic, device, IVD, Artificial intelligence / Machine learning, software as a medical device (SaMD), usability testing
Quality Assurance Engineers and Auditors
Site, Sponsor, Vendor auditors
Quality Management Systems (QMS)
483/Warning Letter response and mitigation
Regulatory Strategies & Submissions
FDA Regulatory Agent, Pre-IND, Q-Sub, Pre-IDE, IND/IDE, 513(g), 510(k), De Novo, PMA, NDA, BLA, Breakthrough, etc.
Technical Files and Design Dossiers
EU MDR Literature Reviews and Clinical Evaluation Reports
Protocols, Investigator Brochures, Technical Documents
Medical Experts/Medical Monitors
Medical oncologists, surgeons, intensivists, internists, primary care, most other specialties covered
LET’S TEAM UP TO GIVE YOU YOUR BEST SHOT AT A SUCCESSFUL LAUNCH
Contact us today for a free phone consultation.